ストックスクリーナーアプリを入手
3.18
3.25%
0.10
アフターアワーズ：
3.19
0.010
+0.31%
前日終値:
$3.08
開ける：
$3.01
24時間の取引高:
51,696
Relative Volume:
2.82
時価総額：
$18.15M
収益：
$22.38M
当期純損益:
$-13.33M
株価収益率:
-0.702
EPS:
-4.53
ネットキャッシュフロー:
$-8.06M
1週間 パフォーマンス:
+15.64%
1か月 パフォーマンス:
+2.25%
6か月 パフォーマンス:
-50.89%
1年 パフォーマンス:
-24.29%
1日の値動き範囲:
$2.92
$3.18
1週間の範囲:
$2.64
$3.18
52週間の値動き範囲:
$2.36
$7.5498
Ezfill Holdings Inc Stock (EZFL) Company Profile
Ezfill Holdings Inc (EZFL) 最新ニュース
Yoshi Mobility Agrees to Sell Its Fleet Fueling Operation to EZFill Holdings - NGT News
EzFill to acquire Yoshi fueling division, eyes national expansion - Investing.com
Yoshi Mobility goes green, spins off fueling division - StockTitan
EzFill Fueling up to Expand Nationally Enters into LOI for the Acquisition of Yoshi Mobility’s Fuel Division - GlobeNewswire
EZFill Holdings Inc. signed a letter of intent to acquire Fueling division of Yoshi, Inc. - Marketscreener.com
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and Milton - GlobeNewswire
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and - EIN News
EzFill Holdings revises share exchange in NextNRG acquisition - Investing.com
EzFill Holdings revises share exchange in NextNRG acquisition By Investing.com - Investing.com Canada
EZFill Holdings Inc. (NASDAQ:EZFL) Short Interest Down 56.5% in September - Defense World
FDA Approves Miplyffa for Niemann-Pick Disease, Type C - MyChesCo
FDA Approves Miplyffa for Ultra Rare Niemann-Pick Disease Type C - Managed Healthcare Executive
FDA approves Zevra’s Miplyffa for Niemann-Pick disease type C treatment - World Pharmaceutical Frontiers
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 - Investing.com
Ezzaty Abdullah admits to be delivering her baby soon - Yahoo Lifestyle Singapore
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease - Pharmaceutical Technology
FDA clears first drug for Niemann-Pick disease - pharmaphorum
Zevra’s Miplyffa wins first FDA approval in Niemann-Pick type C - BioWorld Online
EzFill Holdings (NASDAQ:EZFL) Stock Quotes, Forecast and News Summary - Benzinga
After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa - FiercePharma
First Drug Approved for Niemann-Pick Disease Type C - Medpage Today
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease - Benzinga
Arimoclomol Becomes First FDA Approved Treatment for Neimann-Pick Disease Type C - Pharmacy Times
FDA approves first Niemann-Pick disease, type C treatment - The Pharma Letter
FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C - Contemporary Pediatrics
EZFill Holdings Inc. (NASDAQ:EZFL) CTO Sells $20,550.00 in Stock - Defense World
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k - Investing.com India
Extra Storage rises on Jefferies upgrade - XM
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 - Investing.com India
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 By Investing.com - Investing.com Australia
Correction to Eli Lilly Gets FDA Approval for Eczema Treatment Article - Morningstar
Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss - MarketWatch
FDA Approves Eli Lilly's Drug for Eczema - Newsmax
Insider Sale: CTO Avishai Vaknin Sells Shares of EzFill Holdings Inc (EZFL) By GuruFocus - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock By Investing.com - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock - Investing.com
EzFill holdings CTO Avishai Vaknin sells shares worth over $15k - Investing.com
EzFill regains compliance with Nasdaq's equity rule - Investing.com
EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring - TipRanks
EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard - GlobeNewswire
EzFill Holdings Inc’s latest rating changes from various analysts - Knox Daily
Daily Market Movement: EzFill Holdings Inc (EZFL) Sees a -3.27 Decrease, Closing at 2.96 - The Dwinnex
EZFill Holdings Inc. (NASDAQ:EZFL) Short Interest Update - Defense World
EZFL: Synergies of Pending Merger; Balance Sheet Measures Expected to Reduce Debt, Interest Expense & Regain Nasdaq Compliance… - MSN
An Analysis of EzFill Holdings Inc (EZFL)’s Potential Price Growth - Knox Daily
EZFill Holdings Inc. (NASDAQ:EZFL) Stock's 35% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
EzFill converts debt to equity, gains $1.4m investment By Investing.com - Investing.com India
EZFill Holdings Second Quarter 2024 Earnings: US$1.67 loss per share (vs US$1.78 loss in 2Q 2023) - Yahoo Finance
Ezfill Holdings Inc (EZFL) 財務データ
収益
当期純利益
現金流量
EPS
Ezfill Holdings Inc (EZFL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Vaknin Avishai | Chief Technology Officer |
Sep 20 '24 |
Sale |
3.45 |
5 |
17 |
65,977 |
| Vaknin Avishai | Chief Technology Officer |
Sep 17 '24 |
Sale |
4.20 |
5,061 |
21,244 |
68,933 |
| Vaknin Avishai | Chief Technology Officer |
Sep 18 '24 |
Sale |
3.72 |
2,246 |
8,354 |
66,626 |
0.05%
大文字化:
|
ボリューム (24 時間):